Involving Fixed Or Stabilized, Nonliving Microorganism, Cell, Or Tissue (e.g., Processes Of Staining, Stabilizing, Dehydrating, Etc.; Compositions Used Therefore, Etc.) Patents (Class 435/40.5)
-
Patent number: 7745168Abstract: The present invention provides a method for the staining of fungi and microsporidia for observation with a light microscope based upon the presence of chitin in the composition of these organisms. With the method of the present invention a sample to be analyzed is treated with a solution of Ponceau S and Stains-all dye. The sample is then selectively decolorized and rinsed. The resulting sample is examined with a light microscope, or photographed for a permanent record, to identify the presence of a variety of microorganisms, to include fungi and microsporidia.Type: GrantFiled: October 2, 2006Date of Patent: June 29, 2010Assignee: University of South FloridaInventor: My Lien Dao
-
Publication number: 20100159507Abstract: The systems and techniques of the present invention can also synergistically utilize mechanical disruption processes with the use of high hydrostatic pressure extraction, such as pressure cycling extraction techniques to achieve high yield of difficult to extract sample constituents without generating high shear stress or high temperatures.Type: ApplicationFiled: September 17, 2009Publication date: June 24, 2010Inventors: Edmund Y. Ting, Alexander Lazarev, Vera Gross, Charles Dussault, Chunqin Li, Nathan Lawrence, Richard Schumacher
-
Publication number: 20100159505Abstract: A fluorescent spectroscopic method and apparatus for real time direct detection of transmissible spongiform encephalopathies in central nervous system tissue by monitoring the fluorescence of intrinsic markers in the tissue by illuminating the tissue with UV or visible light having an appropriate wavelength, and the resulting emission spectra is detected and examined in the region from 350 to 650 nm. A higher intensity in this region is indicative of infected tissue. The apparatus and method would not interfere with existing slaughterhouse line speeds or procedures, and could be used on live animals.Type: ApplicationFiled: March 1, 2010Publication date: June 24, 2010Applicants: MEAT INSPECTION SYSTEMS, L.L.C., IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC., The United States, as represented by the Secretary of AgricultureInventors: Thomas A. Casey, Mark A. Rasmussen, Albin H. Gapsch, Ricky Lee Flick, Jacob W. Petrich
-
Publication number: 20100151512Abstract: A haemolysator having a sonotrode plate and oscillation generating elements acting thereupon, wherein the oscillation generating elements are set into mechanical oscillations by an electrical AC-signal generator. The haemolysater also includes a sample chamber to which the sonotrode plate transmits mechanical oscillations, and has oscillation generating elements that are excitable toward mechanical oscillations in a wide frequency band.Type: ApplicationFiled: November 12, 2009Publication date: June 17, 2010Inventor: Herfried Huemer
-
Publication number: 20100151511Abstract: The invention relates to a resealable or a single use cell culture assembly for use in growing, storing and transporting, cell and tissue cultures. The assembly includes a support frame for receiving a base member insert having an upper surface, such as a microscope slide, and a well frame, preferably partitioned into a plurality of well compartments having sidewalls with upper and lower surfaces, upper and lower edges, and upper and lower well openings. The well frame is adapted to be operatively positioned on the upper surface of the base member, and includes a sealing means positioned on or within the lower edge of the well frame. The sealing means is adapted to operatively create a liquid-impermeable releasable seal or barrier when the lower surface of the well frame is positioned on the upper surface of the base member, such that the sealing means is releasably positioned on the upper surface of the base member for maintaining a liquid-impermeable barrier between well compartments.Type: ApplicationFiled: October 22, 2009Publication date: June 17, 2010Applicant: Millipore CorporationInventors: Kurt E. Greenizen, Phillip Clark, John J. Doyle
-
Publication number: 20100151510Abstract: A cell culture substrate having at least one area for culturing a cell on a substrate, characterized in that the culturing area comprises an area releasably holding a biologically active substance having a biological activity to the cell and an area for immobilizing a biologically active substance having a biological activity to the cell.Type: ApplicationFiled: February 23, 2010Publication date: June 17, 2010Applicant: CANON KABUSHIKI KAISHAInventors: Osamu Kanome, Kohei Watanabe, Takeshi Miyazaki, Tomoyo Fujiyama, Ryoichi Matsuda
-
Publication number: 20100136612Abstract: The present invention relates to a method for enhancing immunoreactivity of a tissue or cell sample fixed in a fixing medium, a target retrieval composition and its use. The method comprises providing a carrier in a horizontal position, said carrier having thereon a tissue or cell sample, said tissue or cell sample being on top of the carrier; contacting substantially the tissue or cell sample side of the carrier with a buffered target retrieval solution, wherein the target retrieval solution remains otherwise exposed to the environment; heating the tissue or cell sample and the target retrieval solution to a temperature above 100° C. The invention furthermore concerns the automated immunohistochemical staining of said samples, in particular the reactivation of antigens masked by fixation.Type: ApplicationFiled: February 11, 2008Publication date: June 3, 2010Inventors: Nanna K. Christensen, Lars Winther
-
Patent number: 7718395Abstract: A method for monitoring cleaning of a surface includes applying an amount of transparent indicator material to an area of a surface and measuring the amount of transparent indicator material remaining on the surface. The transparent indicator material may be fixed on the surface by drying and, when a fluorescent material, may be measured through exposure to ultraviolet radiation.Type: GrantFiled: January 19, 2006Date of Patent: May 18, 2010Assignee: Kleancheck Systems, LLCInventor: Philip C. Carling
-
Patent number: 7713743Abstract: For successful wound healing to occur, the newly formed skin must generate tensile strength through collagen deposition. Measurement of collagen in the granulating wound bed may be predictive of successful wound healing. Existing methods for collagen measurement either require specialized equipment, or do not allow for discrimination of potential interfering molecules. Herein described is an accurate, specific and reliable method to extract and quantify collagen from tissue utilizing high pressure liquid chromatography techniques. The method is sensitive enough to measure the small amounts of collagen found in newly healing wounds.Type: GrantFiled: February 9, 2009Date of Patent: May 11, 2010Assignee: KCI Licensing, Inc.Inventors: Patricia A. Villanueva, Amy K. McNulty, Herbert D. Beniker, Kristine Kieswetter
-
Publication number: 20100112584Abstract: Cyanine compounds having the general formula I for staining biological samples, wherein R1, R2, X, Y, A1 and A2 are as defined in the specification. These kinds of compounds may show good light illumination stability, have a maximum absorption peak around 640 nm that may not change as a function of ambient temperature, have rapidly increased fluorescence intensity upon binding to nucleic acids to form compound/nucleic acid complexes, and have a light spectrum in the near-infrared region, thereby effectively reducing interference from background fluorescence and increasing the accuracy of the detection when used as a staining agent for nucleic acids in a flow cytometer. The compounds provided can be used as a staining agent for erythroblasts in the blood.Type: ApplicationFiled: October 28, 2009Publication date: May 6, 2010Applicant: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.Inventors: Jianhui Shao, Bing Xu
-
Publication number: 20100105104Abstract: The present invention provides a method, a chip device, and a system for quantitatively measuring intercellularly and intracellularly-localized mRNA and protein without loss of local space information. In the present invention, cell content is trapped atop a substrate or an electrode in the form of a two-dimensional projection of a cell. Accordingly, electrophoretic force is used, or the cellular moisture content is instantaneously evaporated and immobilized. mRNA immobilized to a two-dimensional surface is identified with a labeled probe which hybridizes to the mRNA.Type: ApplicationFiled: March 5, 2007Publication date: April 29, 2010Applicant: On-Chip Cellomics ConsortiumInventors: Kazunori Okano, Kenji Yasuda
-
Publication number: 20100105105Abstract: Methods of microscopic imaging of biological tissue using adaptive optics technology to improve the image focus and sharpness. Wavefront measurements are taken by using a novel method of seeding biological tissue by using a fluorescent microsphere as a “guide star” as a natural point-source reference. The current methods are capable of improving the Strehl ratio of modern biological microscopes as much as 15 times.Type: ApplicationFiled: October 24, 2009Publication date: April 29, 2010Applicant: The Regents of the University of California, Office of Technology TransferInventors: Oscar Azucena, Joel Kubby, Jian Cao, William Sullivan
-
Patent number: 7705989Abstract: A surface plasmon microsensor or a nanosensor for chemical or biological species including pads distributed on the surface of a support, the pads including an electrically conductive material and being capable of immobilizing the chemical or biological species. The pads have a dimension less than 1 ?m.Type: GrantFiled: October 7, 2004Date of Patent: April 27, 2010Assignee: Commissariat A l'Energie AtomiqueInventors: Patrick Chaton, Jean-Louis Bijeon, Pascal Royer, Pierre Michel Adam
-
Publication number: 20100093021Abstract: Sintering self-assemblies of calcined colloidal silica particles results in sintered colloidal crystals that are free of cracks that can be resolved using optical microscopy. The sintered colloidal crystals have significantly improved strength and durability, and withstand aggressive handling. Surface rehydroxylation of the sintered colloidal crystals enables subsequent chemical modification.Type: ApplicationFiled: November 20, 2009Publication date: April 15, 2010Applicant: THE ARIZONA BD OF REG ON BEHALF OF THE UNIV OF AZInventors: Mary J. Wirth, Thai Van Le, Suping Zheng
-
Patent number: 7695926Abstract: The invention provides methods and compositions for simultaneously detecting the activation state of a plurality of proteins in single cells using flow cytometry. The invention further provides methods and compositions of screening for bioactive agents capable of coordinately modulating the activity of a plurality of proteins in single cells. The methods and compositions can be used to determine the protein activation profile of a cell for predicting or diagnosing a disease state, and for monitoring treatment of a disease state.Type: GrantFiled: January 18, 2007Date of Patent: April 13, 2010Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Omar D. Perez, Garry P. Nolan
-
Patent number: 7691590Abstract: Oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents are used to reduce OMgp-mediated axon growth inhibition. Mixtures of axons and OMgp and mixtures of Nogo receptor (NgR) and OMgp are used in pharmaceutical screens to characterize agents as inhibiting binding of NgR to OMgp and promoting axon regeneration.Type: GrantFiled: December 18, 2007Date of Patent: April 6, 2010Assignee: Children's Medical Center CorporationInventors: Zhigang He, Kevin C. Wang, Vuk Koprivica, Jieun A. Kim
-
Publication number: 20100075373Abstract: A method including: providing a sample with M components to be labeled, where M>2; labeling the components with N stains, where N<M so that at least two components are labeled with a common stain; obtaining a set of spectral images of the sample; classifying different parts of the sample into respective classes that distinguish the commonly stained components based on the set of spectral images; and determining relative amounts of multiple ones of the M components in different regions of the sample. Related apparatus are also disclosed.Type: ApplicationFiled: September 22, 2009Publication date: March 25, 2010Inventor: Clifford C. Hoyt
-
Publication number: 20100075372Abstract: The present invention provides a method for deparaffinization useful for mass spectrometric imaging from a paraffin-embedded specimen. A method for deparaffinization of paraffin-embedded specimen comprising the steps of: exposing a biological sample by subjecting a specimen in which the biological sample is embedded in paraffin, to an organic solvent that is compatible with the paraffin under heating condition, to make the paraffin be melted and dissolved in the organic solvent; and removing the paraffin from the specimen by separating the organic solvent dissolving the paraffin, from the exposed biological sample.Type: ApplicationFiled: September 21, 2007Publication date: March 25, 2010Inventors: Taka-aki Sato, Yutaka Aoki, Takashi Shimada, Atsuhiko Toyama
-
Publication number: 20100075322Abstract: The invention relates to a method of testing for a mycotoxin in patient tissue or body fluid and testing for a fungal species in the patient tissue or body fluid. The method can also be used to determine if a patient is at risk for or has developed a disease state related to a fungal infection, and to develop an effective treatment regimen for the patient.Type: ApplicationFiled: August 21, 2009Publication date: March 25, 2010Inventor: Dennis G. Hooper
-
Patent number: 7682799Abstract: This application relates to a newly identified animal cell structure, the midbody scar. This structure is a remnant of the midbody that is retained by one daughter cell following cytokinesis and persists through multiple subsequent cell cycles. The midbody scar can be useful as a marker of dividing cells or of a cell's replicative age.Type: GrantFiled: October 6, 2006Date of Patent: March 23, 2010Assignee: University of MassachusettsInventors: Stephen J. Doxsey, Chun-Ting Chen
-
Publication number: 20100068757Abstract: An automated microscope slide staining system and staining apparatus and method that features a plurality of individually operable miniaturized pressurizable reaction compartments or a pressurizable common chamber for individually and independently processing a plurality of microscope slides. The apparatus preferably features independently movable slide support elements each having an individually operable heating element.Type: ApplicationFiled: August 28, 2009Publication date: March 18, 2010Inventor: Lee H. Angros
-
Publication number: 20100068690Abstract: This invention relates, e.g., to a composition that, at room temperature, when contacted with a sample comprising phosphoproteins, can fix and stabilize cellular phosphoproteins, preserve cellular morphology, and allow the sample to be frozen to generate a cryostat frozen section suitable for molecular analysis. The composition comprises (1) a fixative that is effective to fix the phosphoproteins, and that has a sufficient water content to be soluble for a stabilizer and/or a permeability enhancing agent); (2) a stabilizer, comprising (a) a kinase inhibitor and (b) a phosphatase inhibitor and, optionally, (c) a protease (e.g., proteinase) inhibitor; and (3) a permeability enhancing agent (e.g. PEG). Methods are described for preserving phosphoproteins, using such a composition. Also described are endogenous surrogate markers for monitoring protein degradation, including the loss of posttranslational modifications (such as phosphorylation), e.g.Type: ApplicationFiled: October 26, 2007Publication date: March 18, 2010Applicant: George Mason Intellectual Properties, Inc.Inventors: Lance A. Liotta, Emmanuel F. Petricoin, III, David Geho, Virginia A. Espina
-
Patent number: 7678574Abstract: The invention provides for a process for preparing a sensitivity control for blood group determination including dissolving an amount of an antigen in water to give an antigen solution of known concentration, contacting the antigen solution with cells to allow insertion of antigen molecules into the cell membranes of the cells to give transformed cells or contacting the antigen solution with cells that have been modified by the insertion of a linker molecule into the membranes of the cells to allow attachment of antigen molecules to the linker molecules to give transformed cells, washing the transformed cells to give a transformed cell solution, and determining the concentration of the transformed cell solution to enable the solution to be used as a sensitivity control for blood group determination.Type: GrantFiled: October 16, 2002Date of Patent: March 16, 2010Assignee: KIWI Ingenuity LimitedInventors: Deborah Adella Blake, Lissa Gwyneth Gilliver, Stephen Michael Henry, Ji Chen
-
Publication number: 20100062418Abstract: In one aspect, the present invention provides biological sample that includes a dry preparation comprising a stabilizer and stabilized, inactivated biological material. In certain embodiments, the biological material may be heat inactivated and/or heat dried. In another aspect, the present invention provides a method of making a dried biological preparation. Generally, the method includes collecting a sample of biological material, inactivating the biological material, suspending the sample in a volume of a stabilizer and allowing the stabilizer to dry. In certain embodiments, the biological material may be heat inactivated and/or heat dried.Type: ApplicationFiled: November 15, 2007Publication date: March 11, 2010Inventors: Patrick A. Mach, Tera M. Nordby, Mara S. Reif-Wenner
-
Patent number: 7670798Abstract: The present invention describes semi- and fully-automated methods and reagents therefor for the assay and analysis of body fluid samples, particularly non-blood samples. The methods and reagents are especially useful for the assay and analysis of cerebrospinal fluid (CSF) samples. The reagent compositions sphere and fix all cells in the sample in suspension. Reported results can include red blood cell (RBC) and white blood cell (WBC) counts, WBC differential values, cell-by-cell volumes and dry-mass concentrations.Type: GrantFiled: May 20, 2003Date of Patent: March 2, 2010Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Leonard Ornstein, Gena Fischer, David Zelmanovic, Pamela Elsins, Jolanta Kunicka, Michael J. Malin
-
Patent number: 7670799Abstract: Presented is a method of solubilizing TCPP, as well as a composition comprising TCPP solubilized by this method.Type: GrantFiled: June 5, 2008Date of Patent: March 2, 2010Assignee: Biomoda, Inc.Inventor: Jeffrey L. Garwin
-
Publication number: 20100047859Abstract: A composition including the reaction product of: an organic silane of Formula SiR1mX14-m; a fluorescent dye-silane compound of Formula D-L?-(CH2)n—SiX23; water; and a hydrolysis catalyst; where R1 is a C1-C6 alkyl that is unsubstituted or substituted with one or more halogens or hydroxyl group, C2-C6 alkenyl that is unsubstituted or substituted with one or more halogens or hydroxyl group, or an aryl group that is unsubstituted or substituted with one or more halogens or hydroxyl group, m is 0 or 1; n is 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, D is a radical having a fluorophore; L1 is a bond, O, S, C(O)O, C(O)NR2, SO2O, C(O)S, C(S), or S2; R2 is hydrogen, a C1-C12 alkyl that is unsubstituted or is substituted with hydroxyl; each X1 and X2 are independently a hydrolyzable substituent; and the reaction product is a silica-based fluorescent nanoparticle.Type: ApplicationFiled: August 22, 2008Publication date: February 25, 2010Inventor: Jin-Kyu Lee
-
Patent number: 7666620Abstract: A method for processing a biological tissue specimen using either manual or automated processing. The tissue specimen is sequentially contacted with components of a reagent system in the presence of increased temperature and/or agitation and in the absence of exogenous microwave radiation to facilitate processing in less than one working day.Type: GrantFiled: November 8, 2006Date of Patent: February 23, 2010Assignee: Richard-Allan Scientific CompanyInventor: J. Gary Wiederhold
-
Patent number: 7666671Abstract: A method of fixing a biological sample on a slide for cytological analysis, includes transferring a sample to a slide, applying a material having a slide-fixing amount of an inactivated, fixative to the slide, and activating the fixative. By way of example, the material may comprise a tape impregnated with the inactivated fixative, which tape may be removed from the slide after the fixative is activated.Type: GrantFiled: October 5, 2006Date of Patent: February 23, 2010Assignee: CYTYC CorporationInventors: Patrick J. McCormick, Kevin Patenaude, Robert Sakal
-
Patent number: 7659082Abstract: The present invention relates to the discovery that mutations in SCN9A are causative of Congenital Indifference to Pain (CIP) in humans. The invention also relates to methods of utilizing the SCN9A gene and expression products thereof for the screening and identification of therapeutic agents, including small organic compounds, which are selective for SCN9A, and are useful in the treatment of pain and other disorders. The invention also relates to methods of using these compounds to treat or otherwise ameliorate such disorders.Type: GrantFiled: February 19, 2003Date of Patent: February 9, 2010Assignee: Xenon Pharmaceuticals Inc.Inventors: Marcia L. MacDonald, Mark E. Samuels, Robin Sherrington, Yigal P. Goldberg
-
Patent number: 7652071Abstract: The invention relates to the use of certain cyclic acetals or ketals for improving the penetration of pharmaceutical agents into cells and organs.Type: GrantFiled: March 25, 2004Date of Patent: January 26, 2010Assignees: Alpha-Biocare GmbH, Convet GmbH & Co. KGInventors: Achim Harder, Iris Heep, Stefan Herrmann, Jeffry-Lynn Grunkemeyer, Jochen Kalbe, Heinz Mehlhorn, Jürgen Schmidt, Günther Schmahl
-
Patent number: 7648678Abstract: The present invention concerns a method and an apparatus for automatic staining of at least one tissue sample accommodated on a slide by applying reagents. The system may include at least one slide provided in a slide rack, a fluid containment element, a slide holder, a vertical slide positioner to pivot the slides to a vertical position, and a slide immerser element to immerse the vertical slide into a fluid containment element or even a dip tank. By pivoting the slides from a horizontal to a vertical position, an automated method and apparatus for carrying out a pretreatment in an automated staining apparatus may be provided. The pivoting of slides may ensure an appropriate orientation of the slides for both the pretreatment and the staining processes.Type: GrantFiled: December 8, 2003Date of Patent: January 19, 2010Assignee: DAKO Denmark A/SInventors: John Favuzzi, Benno Guggenheimer, Jeff Rau, Marc Key, Robert Lathrop, Rosanne Welcher
-
Publication number: 20100009348Abstract: This application provides methods of determining biological activities of a biological sample comprising, for example, comparing the profile of transcription factor activities in a cell contacted with the biological sample to a control profile, such as a profile of transcription factor activities in a cell not contacted with the biological sample.Type: ApplicationFiled: September 27, 2006Publication date: January 14, 2010Inventors: Sergei Romanov, Sergei Makarov
-
Patent number: 7645594Abstract: A method of staining bacteria comprises: working a polymethine dye on a sample in the presence of a substance capable of reducing nitrite ions to stain bacteria in the sample. A method of detecting bacteria comprises the following steps of: (1) working a polymethine dye on a sample by a method as described above to stain bacteria in the sample, (2) introducing the thus treated sample into a detecting part of a flow cytometer and irradiating cells of the stained bacteria one by one with light to measure scattered light and fluorescent light emitted from each of the cells; and (3) discriminating the bacteria from other components in accordance with an intensity of a scattered light signal and an intensity of a fluorescent light signal or a pulse width reflecting the length of particles to count the bacteria.Type: GrantFiled: March 18, 2004Date of Patent: January 12, 2010Assignee: Sysmex CorporationInventors: Yasuhiro Sakai, Yasuyuki Kawashima, Junya Inoue, Yoshiro Ikeuchi
-
Patent number: 7645593Abstract: The present invention relates a method for the enumeration of mammalian cell micronuclei, while distinguishing micronuclei from the chromatin of dead and dying cells. The method utilizes differential staining of chromatin from dead and dying cells, to distinguish the chromatin from micronuclei and nuclei that can be detected based upon fluorescent emission and light scatter following exposure to an excitatory light source. Counting of micronuclei events relative to the number of nuclei can be used to assess the DNA-damaging potential of a chemical agent, the DNA-damaging potential of a physical agent, the effects of an agent which can modify endogenously-induced DNA damage, and the effects of an agent which can modify exogenously-induced DNA damage. Kits for practicing the invention are also disclosed.Type: GrantFiled: October 2, 2008Date of Patent: January 12, 2010Assignee: Litron Laboratories, Ltd.Inventors: Stephen D. Dertinger, Sian E. Cairns, Svetlana L. Avlasevich, Dorothea K. Torous
-
Publication number: 20100004210Abstract: The invention relates to methods for treating T cell mediated autoimmune diseases, such as psoriasis and multiple sclerosis, in a human in need thereof, wherein a therapeutically effective amount of a substance which lowers the cellular glutathione content is administered to the human.Type: ApplicationFiled: May 28, 2009Publication date: January 7, 2010Inventors: Martin Roecken, Kamran Ghoreschi, Christina Mathilde Weigert
-
Publication number: 20100003716Abstract: The present invention provides methods and compositions comprising at least one isoprene synthase enzyme with improved catalytic activity and/or solubility. In particular, the present invention provides variant plant isoprene synthases for increased isoprene production in microbial host cells. Biosynthetically produced isoprene of the present invention finds use in the manufacture of rubber and elastomers.Type: ApplicationFiled: April 23, 2009Publication date: January 7, 2010Inventors: Marguerite A. Cervin, Gregory M. Whited, Andrei Miasnikov, Caroline M. Peres, Walter Weyler, Derek H. Wells, Richard R. Bott
-
Publication number: 20100003679Abstract: A method of assessing cellular composition and fractional viability that can be predictive of post-transplant cell potency and transplantation outcome, comprises identifying cellular composition and assessing cellular viability. This has particular importance in the field of tissue and cell transplantation, cell therapy and regenerative medicine, providing a method for tissue and cell characterization, viability and potency testing, that could be useful for the definition of product release criteria for research and clinical applications.Type: ApplicationFiled: June 8, 2007Publication date: January 7, 2010Applicant: University of MiamiInventors: Hirohito Ichii, Camillo Ricordi
-
Patent number: 7642093Abstract: An automated staining system and a reagent container designed for use with the automated staining apparatus. The reagent container includes a reagent containment section capable of containing a volume of a reagent. The reagent containment section includes an upper wall and a base wall that are spaced apart along an axis. The base wall includes a well having a nadir that is aligned axially with an access opening in the upper wall so that a reagent probe entering the opening parallel to the axis will travel toward the nadir. In another aspect of the invention, the reagent container may include a two-dimensional data element containing reagent information. The staining apparatus may include one removable drawer for holding reagent containers and another removable drawer holding slides.Type: GrantFiled: October 13, 2008Date of Patent: January 5, 2010Assignee: Lab Vision CorporationInventors: Ken K. Tseung, Norman K. Rhett, Glenn K. Takayama, Wai Bun Wong, Delia P. Yuen
-
Publication number: 20090325223Abstract: The subject invention concerns a device for use in staining samples or tissues of interests on slides. The subject invention also concerns methods of using the device to stain a specimen on a slide or to detect antibody and proteins of interest of a tissue section.Type: ApplicationFiled: June 24, 2009Publication date: December 31, 2009Inventor: TIMOTHY BOYD
-
Publication number: 20090325222Abstract: Aspects of the present invention relate to a method for the preparation of samples for MALDI MS imaging. Certain embodiments relate to a method of matrix deposition for samples, wherein tissue sections are prepared via a synergistic combination of fixation with matrix. In certain embodiments, tissue is fixed with cold solvent, according to well-established histology protocols, and in the presence of matrix, allowing for high resolution spatial mapping of protein, lipid, sugar, and/or nucleic acid distribution. In certain embodiments, the present invention relates to fixation with matrix of whole organisms. In certain embodiments, animals are perfused with fixation and matrix mixtures, which allows for direct mass spectrometry analysis.Type: ApplicationFiled: May 24, 2007Publication date: December 31, 2009Applicants: BRANDEIS UNIVERSITY, THE BRIGHAM AND WOMEN'S HOSPITALInventors: Jeffrey N. Agar, Nathalie Y.R. Agar, Peter M. Black
-
Publication number: 20090324500Abstract: The present invention relates to transgenic aquatic vertebrate organisms and methods of their use in screening for, or identifying agents that are useful in modulating the inflammatory response and particularly for identifying agents useful for treating inflammatory disorders.Type: ApplicationFiled: May 14, 2007Publication date: December 31, 2009Inventors: Stephen Andrew Renshaw, Philip William Ingham, Moira Katherine Brigid Whyte
-
Patent number: 7638271Abstract: A method and kit for the detection of an infectious disease, particularly tuberculosis, wherein lymphocytes of a subject are incubated with a disease-specific antigen, and the level of antibody production is measured, the production of antibodies above a baseline level being indicative of infection.Type: GrantFiled: August 2, 2004Date of Patent: December 29, 2009Assignee: ICDDR, B: The Center for Health and Population ResearchInventors: David A. Sack, Rubhana Raquib
-
Publication number: 20090312955Abstract: A bubble point of a combination of a filter and a liquid is calibrated by applying an initial back pressure through the filter toward the liquid; taking a first plurality of measurements of the level of the liquid in the container; calculating a first variance of the first plurality of measurements; and comparing the first calculated variance with a known threshold variance. Then a second plurality of measurements of the level of the liquid in the container is taken; a second variance of the second plurality of measurements is calculated; and the second calculated variance is compared with a known threshold variance. The above described steps are repeated at incrementally increased back pressures until the first and second calculated variances are each greater than or equal to the known threshold variance, which is about 0.01. The bubble point is determined to be the back pressure at that point. If the determined bubble point is less than or equal to the known threshold bubble point, which is about 0.Type: ApplicationFiled: June 11, 2009Publication date: December 17, 2009Applicant: CYTYC CORPORATIONInventors: Timothy Hutchins, Steven A. Scampini, Eric Baur
-
Patent number: 7632652Abstract: The invention is directed to novel compositions of matter and methods of detecting in situ an immunohistochemical epitope or nucleic acid sequence of interest in a biological sample comprising binding an enzyme-labeled conjugate molecule to the epitope or sequence of interest in the presence of a redox-inactive reductive species and a soluble metal ion, thereby facilitating the reduction of the metal ion to a metal atom at or about the point where the enzyme is anchored. Novel phosphate derivatives of reducing agents are described that when exposed to a phosphatase are activated to their reducing form, thereby reducing metal ions to insoluble metal.Type: GrantFiled: June 24, 2004Date of Patent: December 15, 2009Assignee: Ventana Medical Systems, Inc.Inventors: Christopher Bieniarz, Casey A. Kernag, Jerome W. Kosmeder, Paula Rodgers, Jennifer Wong
-
Publication number: 20090305337Abstract: Provided is a system and method for staining of one or more samples, including providing one or more self-contained sample processing receptacles, each of the one or more self-contained sample processing receptacles configured to be inserted into an auto-staining instrument; and enabling one of one or more staining procedures appropriate for the one or more samples as a function of a choice of self-contained sample processing receptacle, each of the one or more self-contained sample processing receptacles configured to process each inserted sample of the one or more samples within the self-contained sample processing receptacle.Type: ApplicationFiled: June 9, 2008Publication date: December 10, 2009Inventors: Shazi Iqbal, Steven M. Montgomery, Ronald Chang, Gregory Mote, Douglas B. Dority, Jeffrey S. Ross
-
Publication number: 20090291467Abstract: The present invention relates to anthraquinone derivatives which act as a fluorophore, to a process for producing said anthraquinone derivatives and their use as fluorophores for staining membranes in live or fixed cells.Type: ApplicationFiled: September 20, 2007Publication date: November 26, 2009Applicant: Universitat HeidelbergInventors: Zuhal Kaya, Roland Krämer
-
Patent number: 7622276Abstract: A method for processing biological tissue used in biological prostheses includes providing a tissue procurement solution formed from a phosphate buffered saline (PBS) solution and a chelating agent. The tissue is transferred from the tissue procurement solution and undergoes chemical fixation. The fixed tissue is then immersed in a series of fresh bioburden reduction process (BRP) solutions to extract phospholipids. The tissue procurement solution reduces the bioburden on the stored tissue and preserves tissue architecture by minimizing tissue swelling. The tissue procurement solution further reduces calcium from the incoming water and/or tissue, and inhibits enzymes that digest the collagen matrix. The serial immersion of the tissue in the fresh bioburden solutions ensures optimal extraction of phospholipids thereby mitigating subsequent calcification of the tissue.Type: GrantFiled: June 6, 2006Date of Patent: November 24, 2009Assignee: Arbor Surgical Technologies, Inc.Inventors: Crystal M. Cunanan, Alexandro Ochoa, Ronald E. Cambron
-
Patent number: 7618792Abstract: Disclosed are methods for detecting antibody in a sample, where the antibody targets an antigen expressed by red blood cells or red blood cell ghosts. Rather than detecting the binding events between a particular antigen antibody pair (as in traditional agglutination based assays) the methods herein allow for multiplexed detection of clinically important allo-immune antibodies to blood group antigens. Specifically the method involves generating fluorescently encoded red blood cells or red blood cell ghosts with known antigen presentation and using them to detect the presence of antibody in serum/plasma with a fluorescent sandwich type immunoassay. The assay results can be read using flow cytometric or fluorescent microscope based imaging techniques.Type: GrantFiled: January 6, 2006Date of Patent: November 17, 2009Assignee: BioArray Solutions Ltd.Inventor: Sukanta Banerjee
-
Patent number: 7618784Abstract: Improved methods for assaying the activity of phospholipid transfer protein (PLTP) enhance the signal-to-noise ratio by providing the substrate in donor particles with an aqueous core in the presence of suitable osmotic pressure.Type: GrantFiled: October 23, 2002Date of Patent: November 17, 2009Assignee: Roar Holding LLCInventors: Robert W. Brocia, Xian-Cheng Jiang